Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GABA transporter type 1 (GAT1) is a membrane protein responsible for the reuptake of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the mammalian central nervous system. It plays a crucial role in terminating synaptic transmission and maintaining extracellular GABA homeostasis. GAT1 is predominantly expressed in neurons, especially within presynaptic terminals, but also in certain glial cells. Inhibitors of GAT1 are used therapeutically for epilepsy management. Mutations or dysregulation are implicated in neurological disorders including epilepsy.
Inhibition of GABA reuptake, increasing synaptic and extracellular GABA concentrations
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-Aminobutyric Acid Transporter Type 1 (GAT1).